Trial ID or NCT#
This phase I trial studies the side effects and best dose of panobinostat in treating younger patients with diffuse intrinsic pontine glioma (DIPG). Panobinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Stratum 1 treats patients with DIPG that has returned or gotten worse (progressed). Stratum 2 treats patients with DIPG that has not yet gotten worse. Currently, only Stratum 2 is enrolling patients.
Phase 1 Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma
Contact us to find out if this trial is right for you.
Stefania Ursu Chirita